Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Angela Dispenzieri, MD, of the Mayo Clinic, Rochester, MN, briefly talks on the importance of making sure that patients with newly diagnosed amyloid light-chain (AL) amyloidosis have been diagnosed correctly in order to ensure appropriate treatment. This interview took place during the ninth annual meeting of the Society of Hematologic Oncology (SOHO 2021) congress.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.